Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SON4PEM Study: Sonlicromanol in Post-COVID: A Randomized, Double-blind, Placebo-controlled, Phase II Trial

NCT07298005 is registered in ClinicalTrials.gov with Michele van Vugt as lead sponsor.

NCT NCT07298005
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07298005 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SON4PEM Study: Sonlicromanol in Post-COVID: A Randomized, Double-blind, Placebo-controlled, Phase II Trial
Lead sponsor
Michele van Vugt
Phase
Phase 2
Overall status
Recruiting
Start date
April 3, 2026
Completion date
March 31, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post covid condition